Why Do We Need Post-Dilation After Implantation of a Bioresorbable Vascular Scaffold Even for a Soft Lesion?  by Naganuma, Toru et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S VO L . 7 , N O . 9 , 2 0 1 4
ª 2 0 1 4 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 4 . 0 2 . 0 1 7IMAGES IN INTERVENTIONWhy Do We Need Post-Dilation After
Implantation of a Bioresorbable Vascular
Scaffold Even for a Soft Lesion?
Toru Naganuma, MD,*y Azeem Latib, MD,*y Vasileios F. Panoulas, MD,*yz Katsumasa Sato, MD,*y
Tadashi Miyazaki, MD,*y Antonio Colombo, MD*yA 53-year-old man underwent coronary angiog-raphy because of worsening angina, whichdemonstrated a severe noncalciﬁed lesion
in the proximal left anterior descending coronary
artery (LAD) (Figure 1A). Following pre-dilation with
a 3.0-mm balloon, and showing no evidence of
balloon indentation (Figure 1B), intravascularFrom the *Interventional Cardiology Unit, San Raffaele Scientiﬁc Institute
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with a vessel diameter 3.9  4.0-mm at the minimal
lumen area (Figure 1C). A 3.5  18-mm ABSORB bio-
resorbable vascular scaffold (BVS) (Abbott Vascular,
Santa Clara, California) was subsequently implanted.
Despite IVUS showing absence of signiﬁcant calciﬁca-
tion or ﬁbrosis within the plaque, the scaffold balloonFIGURE 1 Coronary Angiography
and IVUS Images of the Left
Coronary System
(A) Pre-procedural angiography
demonstrated a severe noncalciﬁed
lesion on proximal LAD with involve-
ment of a small diagonal branch
(arrow). (B) No indentation of a
3.0-mm balloon for pre-dilation.
(C) IVUS after pre-dilation showed
hypoisoechoic plaque with a vessel
diameter 3.9  4.0 mm. IVUS ¼ intra-
vascular ultrasound; LAD ¼ left anterior
descending coronary artery.
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ly. All other authors have reported that they have no
FIGURE 2 Quantitative Coronary
Angiography of the Inﬂated 3.5-
mm Scaffold Balloon at a Nominal
Pressure
A scaffold balloon inﬂated at a nominal
(NOM) pressure showed almost a “dog
bone sign,” despite surrounding soft
plaque, with balloon diameters:
2.45 mm at the middle, 3.61 mm at the
proximal, and 3.49 mm at the distal
balloon markers. RBP ¼ rated burst
pressure.
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1071revealed an almost “dog bone sign” even after 1 min
of inﬂation at nominal pressure (Figure 2). IVUS
showed underexpansion of the middle segment of
the BVS (Figure 3A), therefore, post-dilation with a
3.75-mm noncompliant balloon was subsequently
performed without evidence of balloon indentation
(presumed balloon diameter: 3.89 mm at 18 atm).Both angiography and IVUS demonstrated an excel-
lent result with an increase in scaffold area at the
lesion site from 5.5 to 10.4 mm2 (Figure 3B).
There is a consensus that meticulous lesion
preparation and post-dilation with an appropriately
sized balloon are essential for successful BVS im-
plantation (1–4). Of note, the impact of post-dilationFIGURE 3 Angiography Before and
After Post-Dilation With 3.5- and
3.75-mm Noncompliant Balloons
(A) IVUS and angiography showed
underexpansion at the middle segment
of the delivered BVS (SD: 2.4  2.8
mm, SA: 5.5 mm2), despite surrounding
soft plaque, whereas acceptable BVS
expansion was noted at proximal
and distal segments of the BVS. (B)
Angiography after post-dilation with
3.5- and 3.75-mm noncompliant bal-
loons showed an excellent result with
preserved Thrombolysis In Myocardial
Infarction ﬂow grade III to the small
diagonal branch. IVUS showed a signif-
icant increase in minimum SA (from
5.5 to 10.4 mm2). BVS ¼ bioresorbable
vascular scaffold; IVUS ¼ intravascular
ultrasound; NC ¼ noncompliant; SA ¼
scaffold area; SD ¼ scaffold diameter.
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1072has not been well described, and it remains un-
known why BVS balloon inﬂation at nominal pres-
sure recommended by the manufacturer does not
sufﬁce to achieve full expansion of the scaffold.
This case highlights the importance of post-dilation
for optimal BVS implantation even when treating
soft lesions. The same does not hold true for con-
ventional metallic stents, where a similar type of
lesion could have been treated with direct stenting
without post-dilation by some operators. This islikely due to the fact that BVS delivery balloon is
more compliant than the Xience Xpedition one
(Abbott Vascular), to facilitate deliverability of a
scaffold with thicker struts (strut thickness 157 mm
with BVS vs. 81 mm with Xience Xpedition).
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Antonio Colombo, EMO-GVM Centro Cuore Colum-
bus, 48 Via M. Buonarroti, 20145 Milan, Italy. E-mail:
info@emocolumbus.it.RE F E RENCE S1. Latib A, Costopoulos C, Naganuma T,
Colombo A. Which patients could beneﬁt the
most from bioresorbable vascular scaffold
implant: from clinical trials to clinical
practice. Minerva Cardioangiol 2013;61:
255–62.
2. Costopoulos C, Naganuma T, Latib A,
Colombo A. Looking into the future
with bioresorbable vascular scaffolds.Expert Rev Cardiovasc Ther 2013;11:
1407–16.
3. Naganuma T, Basavarajaiah S, Latib A,
Costopoulos C, Colombo A. Use of BVS in a chronic
total occlusion with bifurcation lesion. Int J Cardiol
2013;167:e129–31.
4. Liang M, Kajiya T, Lee C-H, et al. Initial experi-
ence in the clinical use of everolimus-elutingbioresorbable vascular scaffold (BVS) in a
single institution. Int J Cardiol 2013;168:
1536–7.KEY WORDS bioresorbable vascular
scaffold, intravascular ultrasound,
post-dilation
